Knowledge and attitude of pharmacists about Alzheimer's disease: A systematic review

IF 1.3 Q3 EDUCATION, SCIENTIFIC DISCIPLINES

Currents in Pharmacy Teaching and Learning Pub Date : 2025-05-02 DOI:10.1016/j.cptl.2025.102366

Marcela Forgerini , Daniel Alves Cabral , Marília Aparecida Batista dos Santos , Patricia de Carvalho Mastroianni , Tácio de Mendonça Lima

{"title":"Knowledge and attitude of pharmacists about Alzheimer's disease: A systematic review","authors":"Marcela Forgerini , Daniel Alves Cabral , Marília Aparecida Batista dos Santos , Patricia de Carvalho Mastroianni , Tácio de Mendonça Lima","doi":"10.1016/j.cptl.2025.102366","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>To identify studies that explored pharmacists' knowledge and attitudes regarding Alzheimer's Disease (AD).</div></div><div><h3>Methods</h3><div>A comprehensive literature search was conducted in Scopus, Medline (via Pubmed), Latin American and Caribbean Literature in Health Sciences (LILACS), and PsycINFO databases until July 2024. Cross-sectional studies that measured pharmacists' knowledge and attitudes toward AD using structure instruments were included. Two reviewers independently performed the selection of studies, data extraction, and methodological assessment.</div></div><div><h3>Results</h3><div>Ten studies published between 2016 and 2024, involving 7810 participants, were included. Most studies were conducted in Asia (<em>n</em> = 5), in community pharmacies (<em>n</em> = 8), and used the Alzheimer's Disease Knowledge Scale (n = 8). The response rate varied from 8 % to 100 %, while the percentage of correct responses about AD ranged from 50.1 % to 85.3 %. A knowledge gap was identified in areas such as recognizing symptoms, understanding risk factors for AD development, and providing effective patient care. Pharmacists demonstrated greater expertise in the pharmacological management of AD.</div></div><div><h3>Implications</h3><div>The findings suggest the need for training programs and interventions targeting pharmacists working in services that care for patients with AD.</div></div>","PeriodicalId":47501,"journal":{"name":"Currents in Pharmacy Teaching and Learning","volume":"17 8","pages":"Article 102366"},"PeriodicalIF":1.3000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Currents in Pharmacy Teaching and Learning","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877129725000875","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"EDUCATION, SCIENTIFIC DISCIPLINES","Score":null,"Total":0}

引用次数: 0

Abstract

Background

To identify studies that explored pharmacists' knowledge and attitudes regarding Alzheimer's Disease (AD).

Methods

A comprehensive literature search was conducted in Scopus, Medline (via Pubmed), Latin American and Caribbean Literature in Health Sciences (LILACS), and PsycINFO databases until July 2024. Cross-sectional studies that measured pharmacists' knowledge and attitudes toward AD using structure instruments were included. Two reviewers independently performed the selection of studies, data extraction, and methodological assessment.

Results

Ten studies published between 2016 and 2024, involving 7810 participants, were included. Most studies were conducted in Asia (n = 5), in community pharmacies (n = 8), and used the Alzheimer's Disease Knowledge Scale (n = 8). The response rate varied from 8 % to 100 %, while the percentage of correct responses about AD ranged from 50.1 % to 85.3 %. A knowledge gap was identified in areas such as recognizing symptoms, understanding risk factors for AD development, and providing effective patient care. Pharmacists demonstrated greater expertise in the pharmacological management of AD.

Implications

The findings suggest the need for training programs and interventions targeting pharmacists working in services that care for patients with AD.

查看原文本刊更多论文

药师对阿尔茨海默病的知识和态度：一项系统综述

背景：探讨药师对阿尔茨海默病（AD）的知识和态度。方法截止2024年7月，在Scopus、Medline（通过Pubmed）、Latin American and Caribbean literature in Health Sciences （LILACS）和PsycINFO数据库中进行综合文献检索。包括使用结构仪器测量药剂师对AD的知识和态度的横断面研究。两名审稿人独立进行研究选择、数据提取和方法学评估。结果纳入了2016年至2024年间发表的10项研究，涉及7810名参与者。大多数研究在亚洲（n = 5）、社区药房（n = 8）进行，并使用阿尔茨海默病知识量表（n = 8）。应答率从8%到100%不等，而关于AD的正确率从50.1%到85.3%不等。在诸如识别症状、了解阿尔茨海默病发展的危险因素以及提供有效的患者护理等领域发现了知识差距。药剂师在阿尔茨海默病的药理学管理方面表现出更大的专业知识。研究结果表明，有必要针对在护理AD患者的服务中工作的药剂师进行培训计划和干预。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Currents in Pharmacy Teaching and Learning EDUCATION, SCIENTIFIC DISCIPLINES-

CiteScore

2.10

自引率

16.70%

发文量

192